Topics

Samsung BioLogics Company Profile

07:19 EDT 18th September 2019 | BioPortfolio


News Articles [642 Associated News Articles listed on BioPortfolio]

Samsung BioLogics, GI Innovation Ink Second Contract

Samsung BioLogics will provide contract services from the development of cell lines to the production of Phase I drug substances for GI

Samsung BioLogics’ perfusion technology to ‘reduce production time by up to 30%’

Samsung BioLogics announces adoption of perfusion technology with alternating tangential flow for the commercial bioproduction process.

Samsung Biologics to provide CDMO support for ‘bio-venture’ firm GI Innovation

Samsung Biologics is providing contract development services for GI Innovationâs pipeline, with the first among five molecules to initiate development immediately, says company representative.

Samsung Biologics to produce clinical supply as UCB advances Ph I immunotherapy study

Samsung Biologics and UCB agree to an additional drug substance manufacturing deal to produce an anti-tau candidate currently in Phase I clinical trials to treat progressive supranuclear palsy.

Questions mount over Samsung accounting case

An executive at Samsung is issued an arrest warrant, as prosecutors in South Korea continue to look into the accounting case leading up the IPO of Samsung BioLogics.

Authorities raid Korean stock exchange over Samsung BioLogics IPO

Korean authorities continue to place pressure on the CDMO, after prosecutors raided the office of the national stock exchange regarding behaviour preceding the public listing of Samsung BioLogics.

Arrests mount at Samsung over accounting case

A Korean court issued a warrant for the arrest of a Samsung BioLogics executive, as part of the ongoing case regarding whether the company allegedly falsified its value before its IPO in 2016.

Report: Warrant issued for arrest of Samsung BioLogics exec in $3.9B accounting scandal

Drugs and Medications [4 Associated Drugs and Medications listed on BioPortfolio]

Atryn [revo bioloigics, inc.]

These highlights do not include all the information needed to use ATryn safely and effectively. See full prescribing information for ATryn. ATryn, Antithrombin (Recombinant) Lyophilized powder for rec...

Anticoagulant citrate dextrose a [citra labs]

ACD-A Anticoagulant Citrate Dextrose Solution, Solution A, U.S.P., PN 9350, 30 mL NDC 23731-6051-3

Rejuvesol [citra labs llc]

rejuvesol red blood cell processing solution

Renflexis [merck sharp & dohme corp.]

These highlights do not include all the information needed to use RENFLEXIS safely and effectively. See full prescribing information for RENFLEXIS. RENFLEXIS (infliximab-abda) for Injection, for Intra...

PubMed Articles [116 Associated PubMed Articles listed on BioPortfolio]

Biosimilars in India; Current Status and Future Perspectives.

Many key biologics are scheduled to lose their patent by the year 2020, which will provide the opportunity to other biopharmaceutical companies to develop the similar biologics. Biosimilar or similar ...

Cutaneous lymphomas appearing under biologics: 44 cases from the French Study Group on Cutaneous Lymphomas and French Pharmacovigilance Database.

Controversy exists regarding the risk and prognosis of lymphomas under biologics . Risk evaluation must consider the underlying medical condition -as chronic inflammatory diseases are associated with ...

Shifting paradigms revisited: biotechnology and the pharmaceutical sciences.

In 2003 Crommelin et al. published an article titled: 'Shifting paradigms: biopharmaceuticals versus low molecular weight drugs' (https://doi.org/10.1016/S0378-5173(03)00376-4). In the current comment...

The emergence of new biologics for severe asthma.

Patients with severe asthma experience severe symptoms and frequent exacerbations despite intensive treatment with inhaled and oral glucocorticoids. Biologics for severe asthma aim to reduce asthma-re...

Treatment of Psoriasis With Biologics and Apremilast in Patients With a History of Malignancy: A Retrospective Chart Review

Introduction: Biologics have transformed the management of moderate-to-severe psoriasis. The risk of developing a malignancy during treatment is an important consideration, and many studies have been ...

Clinical Trials [128 Associated Clinical Trials listed on BioPortfolio]

Evaluation of the Samsung LABGEO IVD-A20 CHF Test in a Point-of-Care Setting

To establish the performance characteristics of the Samsung LABGEO IVD-A20 CHF Test in intended use settings, by comparing test results of the A20 CHF Test with results obtained from an FD...

Gait Pattern Analysis and Feasibility of Gait Training With a Walking Assist Robot in Stroke Patients and Elderly Adults

The purpose of this study was to investigate the effects of the new wearable hip assist robot developed by Samsung Advanced Institute of Technology (Samsung Electronics Co, Ltd., Korea) to...

A Study Comparing Biologics + Methotrexate With Biologics + Tacrolimus in Patients With Rheumatoid Arthritis (RA)

The purpose of this study is to compare the efficacy of Biologics + Methotrexate with Biologics + Tacrolimus measured by the disease activity score 28 (DAS28) erythrocyte sedimentation rat...

Effect of Gait Training With a Walking Assist Robot on Gait Function and Balance in Patients With Chronic Stroke

The purpose of this study was to investigate the effects of gait training with the new wearable hip assist robot developed by Samsung Advance Institute of Technology (Samsung Electronics C...

Effect of Gait Training With a Walking Assist Robot on Gait Function and Balance in Elderly Adults

The purpose of this study was to investigate the effects of gait training with the new wearable hip assist robot developed by Samsung Advance Institute of Technology (Samsung Electronics C...

Companies [306 Associated Companies listed on BioPortfolio]

Samsung Bioepis Co., Ltd.

Established in 2012, Samsung Bioepis is a biopharmaceutical company committed to increasing patient access to affordable, high-quality biologic medicines. Through innovations in p...

Samsung Electronics America

Samsung Electronics America, Inc. (SEA), based in Ridgefield Park, NJ, is a subsidiary of Samsung Electronics Co., Ltd. The company markets a broad range of award-winning consumer...

Samsung Electronics North America

Samsung Electronics North America (NAHQ), based in Ridgefield Park, NJ, is an arm of Samsung Electronics Co., Ltd. The company markets a broad range of award-winning consumer elec...

Samsung Electronics America, Inc.

Samsung Electronics America, Inc. (SEA), based in Ridgefield Park, NJ, is a subsidiary of Samsung Electronics Co., Ltd. The company markets a broad range of award-winning consumer...

Samsung NEXT

Samsung NEXT builds, grows and scales transformative software and services to complement Samsung’s global hardware footprint. A leading driver of Samsung's transformation int...

More Information about "Samsung BioLogics" on BioPortfolio

We have published hundreds of Samsung BioLogics news stories on BioPortfolio along with dozens of Samsung BioLogics Clinical Trials and PubMed Articles about Samsung BioLogics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Samsung BioLogics Companies in our database. You can also find out about relevant Samsung BioLogics Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks



Searches Linking to this Company Record